Biotech

All Articles

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH prospect

.Novo Nordisk has axed its own once-monthly double GLP-1/ GIP receptor agonist, finishing (PDF) prog...

Daiichi spends Merck $170M to form lung cancer cells T-cell engager treaty

.Merck &amp Co. has quickly redeemed some of the prices of its own Harp on Therapeutics buyout, attr...

BioMarin standstills preclinical gene therapy for heart condition

.After BioMarin performed a spring well-maintained of its pipe in April, the provider has actually m...

Eisai vegetations molecular adhesive SEED with $1.5 B biobucks handle

.Large Pharmas continue to be stuck to the idea of molecular adhesive degraders. The latest provider...

Life science credit report company introduces along with $600M

.A brand new global lifestyle science credit scores organization, termed Symbiotic Funds, has actual...

BMS trenches TIGIT, leaving $200M bank on Agenus bispecific

.Bristol Myers Squibb is axing an additional big bet from the Caforio age, terminating a deal for Ag...

Nuvation stops BET inhibitor after considering phase 1 information

.After looking at period 1 record, Nuvation Biography has actually chosen to halt service its single...

' Professional instinct' led FDA advisors to back Zevra's uncommon health condition med

.Zevra Rehabs' uncommon health condition drug appears to become on the pathway to approval this fall...

Pfizer takes $230M hit after axing failed DMD genetics therapy

.Pfizer's phase 3 Duchenne muscular dystrophy (DMD) genetics treatment breakdown has actually blown ...

AC Immune finds 'spots' prospective in Alzheimer's medication data

.After much more than 20 years of focus on neurodegenerative diseases, Swiss biotech AC Immune syste...